Profile
P.
Martin Petkovich was the founder of Cytochroma, Inc. which was founded in 1996, where he held the title of Chief Scientific Officer from 2009 to 2012.
He also worked as a Principal at Queen's University.
Dr. Petkovich earned a doctorate degree from the University of Toronto in 1986 and an undergraduate degree from McMaster University in 1981.
Former positions of P. Martin Petkovich
| Companies | Position | End |
|---|---|---|
| Queen's University | Corporate Officer/Principal | - |
Cytochroma, Inc.
 Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Founder | - |
Training of P. Martin Petkovich
| McMaster University | Undergraduate Degree |
| University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Cytochroma, Inc.
Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |
- Stock Market
- Insiders
- P. Martin Petkovich
